Roebi A. De Bruijn

Amsterdam, NH 1066CX, Netherlands

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 33 publications

Patient-derived xenograft models of primary breast cancer for preclinical evaluation of neoadjuvant therapies.

Patient-derived xenograft models of primary breast cancer for preclinical evaluation of neoadjuvant therapies.

Journal: Science translational medicine

Published: March 18, 2026

H2AX promotes replication fork degradation and chemosensitivity in BRCA-deficient tumours.

H2AX promotes replication fork degradation and chemosensitivity in BRCA-deficient tumours.

Journal: Nature communications

Published: March 20, 2024

Correction: Functional Categorization of BRCA1 Variants of Uncertain Clinical Significance in Homologous Recombination Repair Complementation Assays.

Correction: Functional Categorization of BRCA1 Variants of Uncertain Clinical Significance in Homologous Recombination Repair Complementation Assays.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research

Published: October 14, 2022

Hormonal status effects on the electrophysiological correlates of performance monitoring in women.

Hormonal status effects on the electrophysiological correlates of performance monitoring in women.

Journal: Psychoneuroendocrinology

Published: September 12, 2022

Multi-omics analysis reveals distinct non-reversion mechanisms of PARPi resistance in BRCA1- versus BRCA2-deficient mammary tumors.

Multi-omics analysis reveals distinct non-reversion mechanisms of PARPi resistance in BRCA1- versus BRCA2-deficient mammary tumors.

Journal: Cell reports

Published: September 06, 2022

Publisher Correction: Truncated FGFR2 is a clinically actionable oncogene in multiple cancers.

Publisher Correction: Truncated FGFR2 is a clinically actionable oncogene in multiple cancers.

Journal: Nature

Published: September 01, 2022

A living biobank of patient-derived ductal carcinoma in situ mouse-intraductal xenografts identifies risk factors for invasive progression.

A living biobank of patient-derived ductal carcinoma in situ mouse-intraductal xenografts identifies risk factors for invasive progression.

Journal: Cancer cell

Published: August 16, 2022

Epithelial-to-Mesenchymal Transition Drives Invasiveness of Breast Cancer Brain Metastases.

Epithelial-to-Mesenchymal Transition Drives Invasiveness of Breast Cancer Brain Metastases.

Journal: Cancers

Published: May 25, 2022

CD26-negative and CD26-positive tissue-resident fibroblasts contribute to functionally distinct CAF subpopulations in breast cancer.

CD26-negative and CD26-positive tissue-resident fibroblasts contribute to functionally distinct CAF subpopulations in breast cancer.

Journal: Nature communications

Published: May 18, 2022

Homologous recombination deficiency derived from whole-genome sequencing predicts platinum response in triple-negative breast cancers.

Homologous recombination deficiency derived from whole-genome sequencing predicts platinum response in triple-negative breast cancers.

Journal: Nature communications

Published: April 14, 2022

Combined inhibition of EZH2 and ATM is synthetic lethal in BRCA1-deficient breast cancer.

Combined inhibition of EZH2 and ATM is synthetic lethal in BRCA1-deficient breast cancer.

Journal: Breast cancer research : BCR

Published: June 02, 2021

A BRCA1 Coiled-Coil Domain Variant Disrupting PALB2 Interaction Promotes the Development of Mammary Tumors and Confers a Targetable Defect in Homologous Recombination Repair.

A BRCA1 Coiled-Coil Domain Variant Disrupting PALB2 Interaction Promotes the Development of Mammary Tumors and Confers a Targetable Defect in Homologous Recombination Repair.

Journal: Cancer research

Published: May 05, 2021

Showing 1-12 of 33

Last Updated: 09/26/2026